What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Blood pressure
- Enzyme
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Renin–angiotensin system, Blood pressure and Angiotensin II.
His Internal medicine study combines topics in areas such as Placebo and Cardiology.
The concepts of his Endocrinology study are interwoven with issues in Pharmacology and Enzyme inhibitor.
His Renin–angiotensin system research includes themes of Angiotensin-converting enzyme, ACE inhibitor, Kidney and Captopril.
The study incorporates disciplines such as General practice, Cohort and Urology in addition to Blood pressure.
While the research belongs to areas of Heart failure, Joël Ménard spends his time largely on the problem of Myocardial infarction, intersecting his research to questions surrounding Vascular disease, Stroke, Diabetes mellitus, Perindopril/indapamide and Aspirin.
His most cited work include:
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial (5031 citations)
- Evidence-Based Medicine: A New Approach to Teaching the Practice of Medicine (3122 citations)
- Cardiovascular Prognosis of Masked Hypertension Detected by Blood Pressure Self-measurement in Elderly Treated Hypertensive Patients (724 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Endocrinology, Renin–angiotensin system, Blood pressure and Plasma renin activity.
His work deals with themes such as Pharmacology and Cardiology, which intersect with Internal medicine.
His studies link Hemodynamics with Endocrinology.
He combines subjects such as Radioimmunoassay, Biochemistry, Enzyme, Angiotensin II and Kidney with his study of Renin–angiotensin system.
The various areas that Joël Ménard examines in his Blood pressure study include Anesthesia, Placebo, Surgery and Urology.
His research on Plasma renin activity frequently connects to adjacent areas such as Acebutolol.
He most often published in these fields:
- Internal medicine (58.10%)
- Endocrinology (49.07%)
- Renin–angiotensin system (41.90%)
What were the highlights of his more recent work (between 2007-2021)?
- Internal medicine (58.10%)
- Endocrinology (49.07%)
- Blood pressure (29.17%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Endocrinology, Blood pressure, Renin–angiotensin system and Plasma renin activity.
His studies deal with areas such as Placebo and Cardiology as well as Internal medicine.
His study looks at the relationship between Placebo and fields such as Myocardial infarction, as well as how they intersect with chemical problems.
His Blood pressure research is multidisciplinary, incorporating elements of Copeptin, Vasopressin, Randomized controlled trial and Pediatrics.
His study in Renin–angiotensin system is interdisciplinary in nature, drawing from both Angiotensin II, Computational biology, Pharmacology and Protein chemistry.
His Plasma renin activity research is multidisciplinary, relying on both Kidney and Renin inhibitor.
Between 2007 and 2021, his most popular works were:
- Clearance systems in the brain—implications for Alzheimer disease (632 citations)
- Masked hypertension: a systematic review. (206 citations)
- A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. (160 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Enzyme
- Blood pressure
Internal medicine, Endocrinology, Aldosterone, Plasma renin activity and Aldosterone synthase are his primary areas of study.
His study ties his expertise on Placebo together with the subject of Internal medicine.
His Plasma renin activity research is included under the broader classification of Renin–angiotensin system.
His Renin–angiotensin system study combines topics from a wide range of disciplines, such as Angiotensin II and Pharmacology.
His Mineralocorticoid study frequently links to related topics such as Blood pressure.
His studies in Blood pressure integrate themes in fields like Hazard ratio, Framingham Risk Score, Randomized controlled trial and Urology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
